Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Non-Current Assets: 2023-2024

Historic Non-Current Assets for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $2.6 million.

  • Upstream Bio's Non-Current Assets fell 59.87% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 59.87%. This contributed to the annual value of $2.6 million for FY2024, which is 1166.83% up from last year.
  • Latest data reveals that Upstream Bio reported Non-Current Assets of $2.6 million as of FY2024, which was up 1,166.83% from $202,000 recorded in FY2023.
  • In the past 5 years, Upstream Bio's Non-Current Assets registered a high of $2.6 million during FY2024, and its lowest value of $202,000 during FY2023.
  • In the last 2 years, Upstream Bio's Non-Current Assets had a median value of $1.4 million in 2023 and averaged $1.4 million.
  • Data for Upstream Bio's Non-Current Assets shows a peak YoY spiked of 1,166.83% (in 2024) over the last 5 years.
  • Over the past 2 years, Upstream Bio's Non-Current Assets (Yearly) stood at $202,000 in 2023, then soared by 1,166.83% to $2.6 million in 2024.